(VIANEWS) – Huazhu Group (HTHT), Kiniksa Pharmaceuticals, Ltd. (KNSA), Air Lease Corporation (AL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Huazhu Group (HTHT)
33.5% sales growth and 10.64% return on equity
H World Group Limited, together with its subsidiaries, develops leased and owned, manachised, and franchised hotels primarily in the People's Republic of China. The company operates hotels under its own brands, such as HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, Ibis Hotel, JI Hotel, Orange Hotel, Starway Hotel, Ibis Styles Hotel, CitiGO Hotel, Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, MAXX by Steigenberger, Jaz in the City, Grand Mercure, Steigenberger Icon, and Song Hotels. The company was formerly known as Huazhu Group Limited and changed its name to H World Group Limited in June 2022. The company was founded in 2005 and is headquartered in Shanghai, the People's Republic of China.
Earnings Per Share
As for profitability, Huazhu Group has a trailing twelve months EPS of $0.46.
PE Ratio
Huazhu Group has a trailing twelve months price to earnings ratio of 81.39. Meaning, the purchaser of the share is investing $81.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.64%.
Volume
Today’s last reported volume for Huazhu Group is 380203 which is 69.03% below its average volume of 1227880.
2. Kiniksa Pharmaceuticals, Ltd. (KNSA)
15.5% sales growth and 81.84% return on equity
Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need worldwide. Its product candidates include Rilonacept, which is in Phase III clinical trials for the treatment of recurrent pericarditis, an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody that is in Phase II clinical trials for the treatment of giant cell arteritis; and Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition. The company's preclinical product candidates comprise KPL-404, a monoclonal antibody inhibitor of the CD40/CD40L interaction, a central control node of T-cell-dependent, and B-cell-mediated humoral adaptive immunity. The company has a clinical collaboration with Kite Pharma, Inc. to evaluate the combination of Yescarta and Mavrilimumab in patients with relapsed or refractory Large B-Cell lymphoma. Kiniksa Pharmaceuticals, Ltd. was founded in 2015 and is based in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Kiniksa Pharmaceuticals, Ltd. has a trailing twelve months EPS of $3.29.
PE Ratio
Kiniksa Pharmaceuticals, Ltd. has a trailing twelve months price to earnings ratio of 4.73. Meaning, the purchaser of the share is investing $4.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 81.84%.
Moving Average
Kiniksa Pharmaceuticals, Ltd.’s worth is below its 50-day moving average of $16.92 and above its 200-day moving average of $14.62.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 105.3% and a negative 366.7%, respectively.
Yearly Top and Bottom Value
Kiniksa Pharmaceuticals, Ltd.’s stock is valued at $15.57 at 11:22 EST, way under its 52-week high of $20.65 and way above its 52-week low of $10.29.
Sales Growth
Kiniksa Pharmaceuticals, Ltd.’s sales growth is negative 13.4% for the current quarter and 15.5% for the next.
3. Air Lease Corporation (AL)
14.8% sales growth and 7.78% return on equity
Air Lease Corporation, an aircraft leasing company, engages in the purchase and leasing of commercial jet transport aircraft to airlines worldwide. The company also sells aircraft from its operating lease portfolio to third parties, including other leasing companies, financial services companies, and airlines. In addition, it provides fleet management services to investors and owners of aircraft portfolios. As of December 31, 2019, the company owned a fleet of 275 aircraft, including 203 narrowbody jet aircraft and 89 widebody jet aircraft. Air Lease Corporation was founded in 2010 and is headquartered in Los Angeles, California.
Earnings Per Share
As for profitability, Air Lease Corporation has a trailing twelve months EPS of $4.24.
PE Ratio
Air Lease Corporation has a trailing twelve months price to earnings ratio of 7.96. Meaning, the purchaser of the share is investing $7.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.78%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Air Lease Corporation’s EBITDA is 52.45.
4. AAON (AAON)
10.7% sales growth and 25.88% return on equity
AAON, Inc., together with its subsidiaries, engages in engineering, manufacturing, marketing, and selling air conditioning and heating equipment in the United States and Canada. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BasX. It offers rooftop units, data center cooling solutions, cleanroom systems, chillers, packaged outdoor mechanical rooms, air handling units, makeup air units, energy recovery units, condensing units, geothermal/water-source heat pumps, coils, and controls. The company markets and sells its products to retail, manufacturing, educational, lodging, supermarket, data centers, medical and pharmaceutical, and other commercial industries. It sells its products through a network of independent manufacturer representative organizations and internal sales force. The company was incorporated in 1987 and is based in Tulsa, Oklahoma.
Earnings Per Share
As for profitability, AAON has a trailing twelve months EPS of $1.81.
PE Ratio
AAON has a trailing twelve months price to earnings ratio of 31.03. Meaning, the purchaser of the share is investing $31.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.88%.
Moving Average
AAON’s value is under its 50-day moving average of $61.01 and below its 200-day moving average of $60.26.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AAON’s EBITDA is 79.57.
5. Ducommun Incorporated (DCO)
7.3% sales growth and 4.32% return on equity
Ducommun Incorporated provides engineering and manufacturing products and services primarily to the aerospace and defense, industrial, medical, and other industries in the United States. It operates through two segments, Electronic Systems and Structural Systems. The Electronic Systems segment provides cable assemblies and interconnect systems; printed circuit board assemblies; higher-level electronic, electromechanical, and mechanical components and assemblies, as well as lightning diversion systems; and radar enclosures, aircraft avionics racks, shipboard communications and control enclosures, shipboard communications and control enclosures, wire harnesses, surge suppressors, conformal shields, and other assemblies. It also supplies engineered products, including illuminated pushbutton switches and panels for aviation and test systems; microwave and millimeter switches and filters for radio frequency systems and test instrumentation; and motors and resolvers for motion control. In addition, this segment provides engineering expertise for aerospace system design, development, integration, and testing. The Structural Systems segment designs, engineers, and manufactures contoured aluminum, titanium, and Inconel aero structure components; structural assembly products, such as winglets, engine components, and fuselage structural panels; and metal and composite bonded structures and assemblies comprising aircraft wing spoilers, large fuselage skins, rotor blades on rotary-wing aircraft and components, flight control surfaces, engine components, and ammunition handling systems. It serves commercial aircraft, military fixed-wing aircraft, military and commercial rotary-wing aircraft, and space programs, as well as industrial, medical, and other end-use markets. The company was founded in 1849 and is headquartered in Santa Ana, California.
Earnings Per Share
As for profitability, Ducommun Incorporated has a trailing twelve months EPS of $1.92.
PE Ratio
Ducommun Incorporated has a trailing twelve months price to earnings ratio of 24.21. Meaning, the purchaser of the share is investing $24.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.32%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Feb 15, 2011, the estimated forward annual dividend yield is 2.08%.
Volume
Today’s last reported volume for Ducommun Incorporated is 14892 which is 82.25% below its average volume of 83929.
6. Getty Realty Corporation (GTY)
7% sales growth and 8.46% return on equity
Getty Realty Corp. is the leading publicly traded real estate investment trust in the United States specializing in the ownership, leasing and financing of convenience store and gasoline station properties. As of September 30, 2020, the Company owned 896 properties and leased 58 properties from third-party landlords in 35 states across the United States and Washington, D.C.
Earnings Per Share
As for profitability, Getty Realty Corporation has a trailing twelve months EPS of $1.42.
PE Ratio
Getty Realty Corporation has a trailing twelve months price to earnings ratio of 18.51. Meaning, the purchaser of the share is investing $18.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.46%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 14.8% and a drop 43.9% for the next.
